Skip to content
A new review article in Science Advances 2023 – TCR-engineered T cell therapy in solid tumors: State of the art and perspectives
Home/Publications & abstracts/A new review article in Science Advances 2023 – TCR-engineered T cell therapy in solid tumors: State of the art and perspectives
A new review article in Science Advances 2023 – TCR-engineered T cell therapy in solid tumors: State of the art and perspectives
webmaster@ervaccinetechnologies.com2023-03-01T21:32:37+00:00
Share on your favorite plateform
Page load link